ARCHIVES

Unclear Whether Clinical Trials Benefit Patients, Review Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal.

March 17, 2006

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program

June 4, 1999